Home » Healthcare » North America Addiction Treatment Market

North America Addiction Treatment Market By Treatment Type (Alcohol Addiction Treatment, Tobacco/Nicotine Addiction Treatment, Opioid Addiction Treatment, Other Substances Addiction Treatment); By Drug Type (Bupropion, Varenicline, Acamprosate, Disulfiram, Naltrexone, Methadone, Buprenorphine, Nicotine Replacement Products, Others); By Treatment Center (Outpatient Treatment Centers, Residential Treatment Centers, Inpatient Treatment Centers); By Distribution Channel (Hospitals Pharmacies, Medical Stores, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
North America Addiction Treatment Market Size 2023	USD 3,131.09 million
North America Addiction Treatment Market, CAGR	6.50%
North America Addiction Treatment Market Size 2032	USD 5,602.23 million

Market Overview

The North America Addiction Treatment Market is projected to grow from USD 3,131.09 million in 2023 to an estimated USD 5,602.23 million by 2032, with a compound annual growth rate (CAGR) of 6.50% from 2024 to 2032. This substantial growth can be attributed to increasing awareness about addiction and its treatment options, along with rising investments in healthcare infrastructure.

Key market drivers include the growing prevalence of substance abuse disorders, advancements in treatment methodologies, and supportive government initiatives. Trends indicate a shift towards outpatient treatment programs and the integration of technology in addiction therapy, such as telemedicine and mobile health applications. These factors are propelling the market forward, making addiction treatment more accessible and effective for individuals across the region.

Geographically, the United States holds the largest market share due to its well-established healthcare system and high incidence of substance abuse cases. Canada follows, with significant contributions from its expanding healthcare sector and supportive policies. Key players in the North America Addiction Treatment Market include Acadia Healthcare, Universal Health Services, Inc., and American Addiction Centers, all of which are continuously innovating to offer comprehensive treatment solutions and enhance patient outcomes. The competitive landscape is marked by strategic collaborations, mergers, and acquisitions aimed at expanding service portfolios and geographic reach.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Drivers

Increasing Prevalence of Substance Abuse Disorders

The rising prevalence of substance abuse disorders is a primary driver of the North America Addiction Treatment Market. According to the National Institute on Drug Abuse, millions of individuals in North America suffer from substance use disorders, encompassing alcohol, prescription drugs, and illicit drugs. For instance, in 2024, it was estimated that 48.7 million Americans aged 12 or older had a substance use disorder. This growing epidemic necessitates a robust response in the form of comprehensive treatment options. The high rates of addiction are often attributed to factors such as stress, socioeconomic conditions, and the easy availability of addictive substances. As the number of affected individuals increases, so does the demand for effective treatment programs, driving market growth. Healthcare providers are continuously adapting to meet this demand by expanding their services and improving the accessibility of treatment facilities. The development of specialized addiction treatment centers and the integration of addiction treatment services into primary healthcare settings are key strategies being employed. Additionally, public health campaigns and community-based programs aim to raise awareness about the dangers of substance abuse and the importance of seeking treatment, further contributing to market growth. This comprehensive approach ensures that individuals battling addiction receive the necessary support and resources to achieve and maintain sobriety.

Advancements in Treatment Methodologies

Advancements in addiction treatment methodologies have significantly impacted the North America Addiction Treatment Market. Traditional methods, such as detoxification and counseling, are being augmented by innovative therapies and medications designed to improve treatment outcomes. For instance, medication-assisted treatment (MAT) combines medications like methadone, buprenorphine, and naltrexone with counseling and behavioral therapies, providing a more holistic approach to addiction management. MAT has proven effective in reducing withdrawal symptoms, curbing cravings, and preventing relapse, making it a cornerstone of modern addiction treatment. Furthermore, the adoption of evidence-based practices and the development of personalized treatment plans tailored to individual needs have enhanced the effectiveness of addiction therapy. Research into the neurobiology of addiction has led to the identification of new therapeutic targets and the development of novel medications. Cognitive-behavioral therapy (CBT), contingency management, and motivational interviewing are some of the psychotherapeutic techniques that have gained prominence due to their proven efficacy. These advancements not only improve patient outcomes but also increase the overall appeal and credibility of addiction treatment programs, driving market growth.

Supportive Government Initiatives and Policies

Government initiatives and policies play a crucial role in driving the North America Addiction Treatment Market. Recognizing the severe impact of substance abuse on public health and the economy, governments across North America have implemented various measures to address the crisis. These initiatives include increased funding for addiction treatment programs, legislative reforms to improve access to care, and the establishment of national strategies to combat substance abuse. For example, the United States has launched several key initiatives, such as the National Drug Control Strategy and the Comprehensive Addiction and Recovery Act (CARA), aimed at enhancing prevention, treatment, and recovery efforts. These initiatives provide grants and funding to support state and local governments, healthcare providers, and community organizations in their efforts to combat addiction. Similarly, Canada has introduced the Canadian Drugs and Substances Strategy (CDSS), which focuses on harm reduction, prevention, treatment, and enforcement to address substance use and its associated harms. These supportive policies not only increase the availability and accessibility of addiction treatment services but also promote the adoption of best practices and the integration of innovative treatment methodologies. By creating a conducive environment for addiction treatment providers, government initiatives significantly contribute to market growth.

Integration of Technology in Addiction Therapy

The integration of technology in addiction therapy is revolutionizing the North America Addiction Treatment Market. Telemedicine, mobile health applications, and digital therapeutic platforms are transforming the way addiction treatment is delivered, making it more accessible, efficient, and patient-centric. Telemedicine enables healthcare providers to offer remote consultations, follow-ups, and counseling sessions, breaking down geographical barriers and ensuring that patients in underserved areas have access to quality care. Mobile health applications, on the other hand, provide patients with tools to track their progress, access educational resources, and connect with support groups. These apps often include features such as reminders for medication adherence, mood tracking, and virtual coaching, empowering patients to take an active role in their recovery journey. Digital therapeutic platforms offer evidence-based interventions through digital means, such as cognitive-behavioral therapy and mindfulness exercises, enhancing the overall treatment experience. The use of technology in addiction therapy not only improves patient engagement and adherence to treatment plans but also allows for continuous monitoring and early intervention in case of relapse. This proactive approach enhances the effectiveness of treatment and contributes to better long-term outcomes. As technology continues to evolve, its integration into addiction treatment will likely become even more sophisticated, further driving market growth.

Market Trends

Increasing Adoption of Outpatient Treatment Programs

One of the notable trends in the North America Addiction Treatment Market is the increasing adoption of outpatient treatment programs. For instance, as of March 31, 2020, there were approximately 12,845 outpatient treatment facilities in the United States. Outpatient treatment offers a flexible and cost-effective alternative to inpatient programs, allowing individuals to receive comprehensive care without the need for residential admission. This trend is driven by the growing recognition of the effectiveness of outpatient programs in providing continuous support while enabling patients to maintain their daily responsibilities, such as work, education, and family commitments. Outpatient programs typically include a combination of individual counseling, group therapy, and medication-assisted treatment (MAT), tailored to meet the unique needs of each patient. The availability of diverse outpatient services, ranging from intensive day programs to less intensive weekly sessions, ensures that patients can access the appropriate level of care based on their severity of addiction and personal circumstances. Moreover, the integration of telemedicine into outpatient programs has further enhanced their accessibility, allowing patients to engage in treatment remotely. This flexibility is particularly beneficial for individuals in rural or underserved areas, where access to specialized addiction treatment facilities may be limited. The shift towards outpatient treatment is also influenced by advancements in therapeutic modalities and the increasing emphasis on community-based care. Healthcare providers are leveraging evidence-based practices and innovative therapies to improve treatment outcomes in outpatient settings. Additionally, the supportive role of family and community in the recovery process is gaining prominence, with outpatient programs encouraging active involvement of family members and fostering a supportive environment for patients. This trend is expected to continue, as outpatient treatment programs offer a sustainable and effective solution for addressing addiction while promoting long-term recovery.

Integration of Behavioral Health and Substance Abuse Treatment

Another significant trend in the North America Addiction Treatment Market is the integration of behavioral health and substance abuse treatment. Recognizing the complex interplay between mental health disorders and substance use disorders, healthcare providers are increasingly adopting an integrated approach to treatment. This trend is based on the understanding that co-occurring disorders, such as depression, anxiety, and post-traumatic stress disorder (PTSD), often exacerbate addiction and hinder recovery. Integrated treatment programs aim to address both substance abuse and underlying mental health issues concurrently, providing a holistic approach to patient care. These programs typically involve a multidisciplinary team of professionals, including addiction specialists, psychiatrists, psychologists, and social workers, who collaborate to develop comprehensive treatment plans. For example, the U.S. Department of Health and Human Services (HHS) has identified opportunities to expand access to behavioral health by integrating behavioral health into primary care settings. By addressing the root causes of addiction and the associated mental health conditions, integrated treatment enhances the effectiveness of interventions and reduces the likelihood of relapse. The integration of behavioral health and substance abuse treatment is supported by advancements in diagnostic tools and therapeutic techniques. Screening and assessment tools are increasingly used to identify co-occurring disorders, enabling healthcare providers to tailor interventions accordingly. Additionally, therapies such as cognitive-behavioral therapy (CBT), dialectical behavior therapy (DBT), and trauma-informed care are being incorporated into addiction treatment programs to address the psychological aspects of addiction.

Market Restraints and Challenges

Stigma and Discrimination Associated with Addiction

One of the most significant restraints in the North America Addiction Treatment Market is the persistent stigma and discrimination associated with addiction. Despite growing awareness about addiction as a medical condition, societal perceptions often label individuals struggling with substance use disorders as morally flawed or lacking self-discipline. This stigma can deter individuals from seeking help due to fear of judgment, shame, and social repercussions. As a result, many people delay or avoid treatment altogether, exacerbating their condition and reducing the effectiveness of early intervention efforts. Discrimination against those with addiction issues is prevalent in various aspects of life, including employment, healthcare, and social interactions. In the workplace, individuals in recovery may face challenges in securing or maintaining jobs, as employers might view them as unreliable or risky hires. In healthcare settings, patients with a history of substance abuse may experience biased treatment, leading to inadequate care or reluctance to disclose their condition to healthcare providers. This widespread stigma not only hinders the market’s growth by reducing the number of individuals seeking treatment but also impacts the overall quality of care provided to those who do. Addressing this challenge requires comprehensive public education campaigns to shift perceptions and promote understanding of addiction as a chronic, treatable condition. Healthcare professionals must also receive training to recognize and mitigate their biases, ensuring equitable and compassionate care for all patients. Policymakers and community leaders play a crucial role in fostering inclusive environments that support recovery and reintegration, ultimately helping to break down the barriers created by stigma and discrimination.

Limited Access to Comprehensive Treatment Services

Another critical challenge facing the North America Addiction Treatment Market is the limited access to comprehensive treatment services, particularly in rural and underserved areas. While urban centers may offer a range of specialized addiction treatment facilities, individuals living in remote or economically disadvantaged regions often struggle to find adequate care. Factors such as geographic isolation, lack of transportation, and insufficient healthcare infrastructure contribute to these disparities, leaving many without the necessary support to overcome addiction. Even in areas where treatment services are available, there can be significant barriers related to affordability and insurance coverage. The cost of addiction treatment, which can include detoxification, therapy, medication-assisted treatment (MAT), and aftercare, is often prohibitive for many individuals and families. Although some insurance plans cover addiction treatment, coverage levels vary, and out-of-pocket expenses can still be substantial. Additionally, navigating insurance claims and approvals can be complex and time-consuming, further deterring individuals from seeking help. To address these challenges, it is essential to expand the availability and accessibility of addiction treatment services across all regions. This includes increasing funding for public treatment programs, incentivizing the establishment of facilities in underserved areas, and leveraging telemedicine to provide remote care. Policymakers should also work towards standardizing insurance coverage for addiction treatment to ensure it is comprehensive and affordable. By improving access to high-quality, affordable treatment options, the market can better meet the needs of individuals struggling with addiction and support their path to recovery.

Market Segmentation Analysis

By Treatment Type

The North America Addiction Treatment Market encompasses several key segments, each addressing different substance use disorders. Alcohol addiction treatment is one of the largest segments due to the high prevalence of alcohol use disorders, utilizing methods such as detoxification, counseling, and medications like disulfiram and naltrexone. The tobacco/nicotine addiction treatment segment is driven by the widespread use of tobacco, with treatments including nicotine replacement therapies (NRTs), bupropion, and varenicline, bolstered by public health campaigns and smoking cessation programs. Opioid addiction treatment is crucial due to the ongoing opioid epidemic, with medication-assisted treatment (MAT) using methadone, buprenorphine, and naltrexone playing a significant role. Finally, the treatment of other substance addictions, such as cocaine, methamphetamine, and cannabis, involves diverse approaches, including behavioral therapies and emerging pharmacological options, to address the varied nature of these disorders.

By Drug Type

The North America Addiction Treatment Market features a range of medications targeting different substance use disorders. Bupropion, known for its dual-action as an antidepressant and smoking cessation aid, is used for tobacco/nicotine addiction and explored for other disorders. Varenicline, effective in smoking cessation by reducing cravings and withdrawal symptoms, holds a significant market share. Acamprosate and disulfiram are key in alcohol addiction treatment, with acamprosate stabilizing brain chemical imbalances and disulfiram deterring alcohol consumption through adverse reactions. Naltrexone treats both alcohol and opioid addictions by blocking euphoric effects and reducing cravings. Methadone and buprenorphine are central in MAT for opioid addiction, with methadone managing withdrawal symptoms and buprenorphine reducing dependency safely. Nicotine replacement products, including patches, gum, and lozenges, provide safer alternatives for smoking cessation. Emerging medications and alternative treatments are also under development, broadening the treatment landscape.

Segments

Based on Treatment Type

Alcohol Addiction Treatment
Tobacco/Nicotine Addiction Treatment
Opioid Addiction Treatment
Other Substances Addiction Treatment

Based on Drug Type

Bupropion
Varenicline
Acamprosate
Disulfiram
Naltrexone
Methadone
Buprenorphine
Nicotine Replacement Products
Others

Based on Treatment Center

Outpatient Treatment Centers
Residential Treatment Centers
Inpatient Treatment Centers

Based on Distribution Channel

Hospitals Pharmacies
Medical Stores
Others

Based on Region

United States
Canada

Regional Analysis

United States (80%):

The United States dominates the North America Addiction Treatment Market, holding an estimated market share of approximately 80%. This leadership position is attributed to several factors, including the high prevalence of substance use disorders, a well-established healthcare infrastructure, and substantial government funding and support for addiction treatment programs. The U.S. faces a severe opioid epidemic, with millions affected by opioid addiction. This crisis has spurred significant investments in addiction treatment facilities and the development of comprehensive care programs.

Canada (20%):

Canada accounts for the remaining 20% of the North America Addiction Treatment Market. While smaller in market share compared to the U.S., Canada exhibits robust growth driven by progressive policies and an expanding healthcare sector. The Canadian government has adopted a public health approach to substance use, emphasizing harm reduction, prevention, and access to treatment. The Canadian Drugs and Substances Strategy (CDSS) underscores these principles, aiming to reduce the harms associated with substance use through comprehensive, evidence-based interventions.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key players

Teva Pharmaceutical Industries Ltd.
Pfizer, Inc.
Alkermes Plc.
Glenmark Pharmaceuticals
GSK plc
Johnson & Johnson Services, Inc.
Novartis AG
Perrigo Company plc
Cipla
Reddy’s Laboratories Limited
Hikma Pharmaceuticals Plc
Indivior Inc.
Mylan N.V.
Eli Lilly and Company
BioCorRx Inc.
Camurus AB

Competitive Analysis

The North America Addiction Treatment Market is highly competitive, with key players employing various strategies to maintain and expand their market positions. Companies such as Pfizer, Inc., and Johnson & Johnson Services, Inc. lead the market through extensive research and development, focusing on innovative therapies and medications. Teva Pharmaceutical Industries Ltd. and Alkermes Plc. leverage their robust product portfolios to cater to diverse addiction treatment needs, including medication-assisted treatment (MAT) for opioid addiction. GSK plc, Novartis AG, and Eli Lilly and Company emphasize the development of new drugs and collaborations to enhance their market presence. Companies like BioCorRx Inc. and Camurus AB are notable for their focus on cutting-edge treatment technologies and delivery systems. Additionally, generic manufacturers such as Glenmark Pharmaceuticals and Dr. Reddy’s Laboratories Limited provide cost-effective treatment options, increasing accessibility for a broader patient base. This competitive landscape drives innovation and ensures a wide range of treatment options are available to meet the growing demand

Recent Developments

In June 2021, Terveystalo Healthcare acquired a 72% shareholding in Feelgood Svenska AB, announcing a proposed required deal at SEK 5.7 per share. This strategic acquisition aims to strengthen Terveystalo’s presence in the Swedish healthcare market and expand its service offerings.

In June 2021, The Ridge announced the opening of a new facility dedicated to providing exclusive private treatment for individuals suffering from drug and alcohol addiction. This center aims to offer personalized care in a supportive environment to help patients achieve lasting recovery.

In May 14, 2024, Lifespan Health System launched a new addiction treatment program called Addiction Care Today. This initiative offers same-day assistance with walk-in and same-day appointments for individuals seeking treatment for substance use disorders, enhancing immediate access to care.

In February 9, 2024, The Union Council of Ministers inaugurated 41 addiction treatment facilities in Delhi, providing free treatment, counseling, and medications for individuals struggling with substance addiction. These centers aim to address the growing need for accessible addiction care services.

In May 2023, Camurus AB, a Swedish biopharmaceutical company, received U.S. FDA approval for Brixadi (buprenorphine) extended-release injection for subcutaneous use. This medication is designed to treat moderate to severe opioid use disorder (OUD), offering a new option for patients in the United States.

Market Concentration and Characteristics

The North America Addiction Treatment Market is characterized by moderate to high market concentration, with several key players dominating the landscape. Major pharmaceutical companies such as Pfizer, Inc., Johnson & Johnson Services, Inc., and Teva Pharmaceutical Industries Ltd. hold significant market shares due to their extensive product portfolios and advanced research capabilities. The market is distinguished by a diverse range of treatment options, including medication-assisted treatments (MAT), behavioral therapies, and integrated care models addressing co-occurring mental health disorders. Additionally, the market is marked by continuous innovation, regulatory support, and a strong emphasis on evidence-based practices, contributing to the development of effective and comprehensive addiction treatment solutions.

Report Coverage

The research report offers an in-depth analysis based on Treatment Type, Drug Type, Treatment Center, Distribution Channel and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The adoption of telemedicine for addiction treatment is expected to expand, providing remote access to counseling and therapy, especially in rural and underserved areas.

Outpatient treatment programs will gain popularity due to their flexibility and cost-effectiveness, allowing patients to receive care while maintaining daily responsibilities.

Continuous advancements in MAT, including the development of new medications, will enhance the effectiveness of addiction treatments and reduce relapse rates.

Integrated care models that address both addiction and co-occurring mental health disorders will become more widespread, offering comprehensive treatment solutions.

Increased collaboration between public health agencies and private sector entities will drive innovation and improve access to high-quality addiction treatment services.

The use of personalized treatment plans based on individual patient needs and genetic profiles will improve treatment outcomes and patient satisfaction.

Public awareness campaigns will continue to educate communities about addiction, reducing stigma and encouraging more individuals to seek treatment.

Advanced diagnostic tools and technologies will be utilized to better identify and assess substance use disorders, leading to more accurate and tailored treatment approaches.

Ongoing research will lead to the development of novel therapeutic approaches, including non-pharmacological treatments, enhancing the diversity of available treatment options.

Insurance coverage for addiction treatment will expand, making it more affordable and accessible, thereby increasing the number of individuals seeking help.

CHAPTER NO. 1 : INTRODUCTION 15

1.1.1. Report Description 15

Purpose of the Report 15

USP & Key Offerings 15

1.1.2. Key Benefits for Stakeholders 15

1.1.3. Target Audience 16

1.1.4. Report Scope 16

CHAPTER NO. 2 : EXECUTIVE SUMMARY 17

2.1. North America Addiction Treatment Market Snapshot 17

2.1.1. North America Addiction Treatment Market, 2018 – 2032 (USD Million) 18

CHAPTER NO. 3 : NORTH AMERICA ADDICTION TREATMENT MARKET – INDUSTRY ANALYSIS 19

3.1. Introduction 19

3.2. Market Drivers 20

3.2.1. Driving Factor 1 Analysis 20

3.2.2. Driving Factor 2 Analysis 21

3.3. Market Restraints 22

3.3.1. Restraining Factor Analysis 22

3.4. Market Opportunities 23

3.4.1. Market Opportunity Analysis 23

3.5. Porter’s Five Forces Analysis 24

CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE 25

4.1. Company Market Share Analysis – 2023 25

4.1.1. North America Addiction Treatment Market: Company Market Share, by Volume, 2023 25

4.1.2. North America Addiction Treatment Market: Company Market Share, by Revenue, 2023 26

4.1.3. North America Addiction Treatment Market: Top 6 Company Market Share, by Revenue, 2023 26

4.1.4. North America Addiction Treatment Market: Top 3 Company Market Share, by Revenue, 2023 27

4.2. North America Addiction Treatment Market Company Revenue Market Share, 2023 28

4.3. Company Assessment Metrics, 2023 29

4.3.1. Stars 29

4.3.2. Emerging Leaders 29

4.3.3. Pervasive Players 29

4.3.4. Participants 29

4.4. Start-ups /SMEs Assessment Metrics, 2023 29

4.4.1. Progressive Companies 29

4.4.2. Responsive Companies 29

4.4.3. Dynamic Companies 29

4.4.4. Starting Blocks 29

4.5. Strategic Developments 30

4.5.1. Acquisitions & Mergers 30

New Product Launch 30

North America Expansion 30

4.6. Key Players Product Matrix 31

CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS 32

5.1. PESTEL 32

5.1.1. Political Factors 32

5.1.2. Economic Factors 32

5.1.3. Social Factors 32

5.1.4. Technological Factors 32

5.1.5. Environmental Factors 32

5.1.6. Legal Factors 32

5.2. Adjacent Market Analysis 32

CHAPTER NO. 6 : NORTH AMERICA ADDICTION TREATMENT MARKET – BY TREATMENT TYPE SEGMENT ANALYSIS 33

6.1. North America Addiction Treatment Market Overview, by Treatment Type Segment 33

6.1.1. North America Addiction Treatment Market Revenue Share, By Treatment Type, 2023 & 2032 34

6.1.2. North America Addiction Treatment Market Attractiveness Analysis, By Treatment Type 35

6.1.3. Incremental Revenue Growth Opportunity, by Treatment Type, 2024 – 2032 35

6.1.4. North America Addiction Treatment Market Revenue, By Treatment Type, 2018, 2023, 2027 & 2032 36

6.2. Alcohol Addiction Treatment 37

6.3. Tobacco/Nicotine Addiction Treatment 38

6.4. Opioid Addiction Treatment 39

6.5. Other Substances Addiction Treatment 40

CHAPTER NO. 7 : NORTH AMERICA ADDICTION TREATMENT MARKET – BY DRUG TYPE SEGMENT ANALYSIS 41

7.1. North America Addiction Treatment Market Overview, by Drug Type Segment 41

7.1.1. North America Addiction Treatment Market Revenue Share, By Drug Type, 2023 & 2032 42

7.1.2. North America Addiction Treatment Market Attractiveness Analysis, By Drug Type 43

7.1.3. Incremental Revenue Growth Opportunity, by Drug Type, 2024 – 2032 43

7.1.4. North America Addiction Treatment Market Revenue, By Drug Type, 2018, 2023, 2027 & 2032 44

7.2. Bupropion 45

7.3. Varenicline 46

7.4. Acamprosate 47

7.5. Disulfiram 48

7.6. Naltrexone 49

7.7. Methadone 49

7.8. Buprenorphine 50

7.9. Nicotine Replacement Products 50

7.10. Others 51

CHAPTER NO. 8 : NORTH AMERICA ADDICTION TREATMENT MARKET – BY TREATMENT CENTER SEGMENT ANALYSIS 52

8.1. North America Addiction Treatment Market Overview, by Treatment Centre Segment 52

8.1.1. North America Addiction Treatment Market Revenue Share, By Treatment Center, 2023 & 2032 53

8.1.2. North America Addiction Treatment Market Attractiveness Analysis, By Treatment Center 54

8.1.3. Incremental Revenue Growth Opportunity, by Treatment Center, 2024 – 2032 54

8.1.4. North America Addiction Treatment Market Revenue, By Treatment Center, 2018, 2023, 2027 & 2032 55

8.2. Outpatient Treatment Centers 56

8.3. Residential Treatment Centers 57

8.4. Inpatient Treatment Centers 58

CHAPTER NO. 9 : NORTH AMERICA ADDICTION TREATMENT MARKET – BY DISTRIBUTION CHANNEL SEGMENT ANALYSIS 59

9.1. North America Addiction Treatment Market Overview, by Distribution Channel Segment 59

9.1.1. North America Addiction Treatment Market Revenue Share, By Distribution Channel, 2023 & 2032 60

9.1.2. North America Addiction Treatment Market Attractiveness Analysis, By Distribution Channel 61

9.1.3. Incremental Revenue Growth Opportunity, by Distribution Channel, 2024 – 2032 61

9.1.4. North America Addiction Treatment Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 62

9.2. Hospitals Pharmacies 63

9.3. Medical Stores 64

9.4. Others 65

CHAPTER NO. 10 : NORTH AMERICA ADDICTION TREATMENT MARKET – NORTH AMERICA 66

10.1. North America 66

10.1.1. Key Highlights 66

10.1.2. North America Addiction Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 67

10.1.3. North America Addiction Treatment Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 68

10.1.4. North America Addiction Treatment Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 69

10.1.5. North America Addiction Treatment Market Revenue, By Treatment Center, 2018 – 2023 (USD Million) 70

10.1.6. North America Addiction Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 71

10.2. U.S. 72

10.3. Canada 72

10.4. Mexico 72

CHAPTER NO. 11 : COMPANY PROFILES 73

11.1. Teva Pharmaceutical Industries Ltd. 73

11.1.1. Company Overview 73

11.1.2. Product Portfolio 73

11.1.3. Swot Analysis 73

11.1.4. Business Strategy 74

11.1.5. Financial Overview 74

11.2. Pfizer, Inc. 75

11.3. Alkremes Plc. 75

11.4. Glenmark Pharmaceuticals 75

11.5. GSK plc 75

11.6. Johnson & Johnson Services, Inc. 75

11.7. Novartis AG 75

11.8. Perrigo Company plc. 75

11.9. Cipla 75

11.10. Dr. Reddy’s Laboratories Limited 75

11.11. Hikma Pharmaceuticals Plc. 75

11.12. Indivior Inc. 75

11.13. Mylan N.V. 75

11.14. Eli Lilly and Company 75

11.15. BioCorRx Inc. 75

11.16. Camurus AB 75

CHAPTER NO. 12 : RESEARCH METHODOLOGY 76

12.1. Research Methodology 76

12.1.1. Phase I – Secondary Research 77

12.1.2. Phase II – Data Modeling 77

Company Share Analysis Model 78

Revenue Based Modeling 78

12.1.3. Phase III – Primary Research 79

12.1.4. Research Limitations 80

Assumptions 80

List of Figures

FIG NO. 1. North America Addiction Treatment Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for North America Addiction Treatment Market 28

FIG NO. 3. Company Share Analysis, 2023 29

FIG NO. 4. Company Share Analysis, 2023 30

FIG NO. 5. Company Share Analysis, 2023 30

FIG NO. 6. Company Share Analysis, 2023 31

FIG NO. 7. North America Addiction Treatment Market – Company Revenue Market Share, 2023 32

FIG NO. 8. North America Addiction Treatment Market Revenue Share, By Treatment Type, 2023 & 2032 38

FIG NO. 9. Market Attractiveness Analysis, By Treatment Type 39

FIG NO. 10. Incremental Revenue Growth Opportunity by Treatment Type, 2024 – 2032 39

FIG NO. 11. North America Addiction Treatment Market Revenue, By Treatment Type, 2018, 2023, 2027 & 2032 40

FIG NO. 12. North America Addiction Treatment Market for Alcohol Addiction Treatment, Revenue (USD Million) 2018 – 2032 41

FIG NO. 13. North America Addiction Treatment Market for Tobacco/Nicotine Addiction Treatment, Revenue (USD Million) 2018 – 2032 42

FIG NO. 14. North America Addiction Treatment Market for Opioid Addiction Treatment, Revenue (USD Million) 2018 – 2032 43

FIG NO. 15. North America Addiction Treatment Market for Other Substances Addiction Treatment, Revenue (USD Million) 2018 – 2032 44

FIG NO. 16. North America Addiction Treatment Market Revenue Share, By Drug Type, 2023 & 2032 46

FIG NO. 17. Market Attractiveness Analysis, By Drug Type 47

FIG NO. 18. Incremental Revenue Growth Opportunity by Drug Type, 2024 – 2032 47

FIG NO. 19. North America Addiction Treatment Market Revenue, By Drug Type, 2018, 2023, 2027 & 2032 48

FIG NO. 20. North America Addiction Treatment Market for Bupropion, Revenue (USD Million) 2018 – 2032 49

FIG NO. 21. North America Addiction Treatment Market for Varenicline, Revenue (USD Million) 2018 – 2032 50

FIG NO. 22. North America Addiction Treatment Market for Acamprosate, Revenue (USD Million) 2018 – 2032 51

FIG NO. 23. North America Addiction Treatment Market for Disulfiram, Revenue (USD Million) 2018 – 2032 52

FIG NO. 24. North America Addiction Treatment Market for Naltrexone, Revenue (USD Million) 2018 – 2032 53

FIG NO. 25. North America Addiction Treatment Market for Methadone, Revenue (USD Million) 2018 – 2032 53

FIG NO. 26. North America Addiction Treatment Market for Buprenorphine, Revenue (USD Million) 2018 – 2032 54

FIG NO. 27. North America Addiction Treatment Market for Nicotine Replacement Products, Revenue (USD Million) 2018 – 2032 54

FIG NO. 28. North America Addiction Treatment Market for Others, Revenue (USD Million) 2018 – 2032 55

FIG NO. 29. North America Addiction Treatment Market Revenue Share, By Treatment Center, 2023 & 2032 57

FIG NO. 30. Market Attractiveness Analysis, By Treatment Center 58

FIG NO. 31. Incremental Revenue Growth Opportunity by Treatment Center, 2024 – 2032 58

FIG NO. 32. North America Addiction Treatment Market Revenue, By Treatment Center, 2018, 2023, 2027 & 2032 59

FIG NO. 33. North America Addiction Treatment Market for Outpatient Treatment Centers, Revenue (USD Million) 2018 – 2032 60

FIG NO. 34. North America Addiction Treatment Market for Residential Treatment Centers, Revenue (USD Million) 2018 – 2032 61

FIG NO. 35. North America Addiction Treatment Market for Inpatient Treatment Centers, Revenue (USD Million) 2018 – 2032 62

FIG NO. 36. North America Addiction Treatment Market Revenue Share, By Distribution Channel, 2023 & 2032 64

FIG NO. 37. Market Attractiveness Analysis, By Distribution Channel 65

FIG NO. 38. Incremental Revenue Growth Opportunity by Distribution Channel, 2024 – 2032 65

FIG NO. 39. North America Addiction Treatment Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 66

FIG NO. 40. North America Addiction Treatment Market for Hospitals Pharmacies, Revenue (USD Million) 2018 – 2032 67

FIG NO. 41. North America Addiction Treatment Market for Medical Stores, Revenue (USD Million) 2018 – 2032 68

FIG NO. 42. North America Addiction Treatment Market for Others, Revenue (USD Million) 2018 – 2032 69

FIG NO. 43. North America Addiction Treatment Market Revenue, 2018 – 2032 (USD Million) 70

FIG NO. 44. Research Methodology – Detailed View 80

FIG NO. 45. Research Methodology 81

List of Tables

TABLE NO. 1. : North America Addiction Treatment Market: Snapshot 21

TABLE NO. 2. : Drivers for the North America Addiction Treatment Market: Impact Analysis 24

TABLE NO. 3. : Restraints for the North America Addiction Treatment Market: Impact Analysis 26

TABLE NO. 4. : North America Addiction Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 71

TABLE NO. 5. : North America Addiction Treatment Market Revenue, By Country, 2024 – 2032 (USD Million) 71

TABLE NO. 6. : North America Addiction Treatment Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 72

TABLE NO. 7. : North America Addiction Treatment Market Revenue, By Treatment Type, 2024 – 2032 (USD Million) 72

TABLE NO. 8. : North America Addiction Treatment Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 73

TABLE NO. 9. : North America Addiction Treatment Market Revenue, By Drug Type, 2024 – 2032 (USD Million) 73

TABLE NO. 10. : North America Addiction Treatment Market Revenue, By Treatment Center, 2018 – 2023 (USD Million) 74

TABLE NO. 11. : North America Addiction Treatment Market Revenue, By Treatment Center, 2024 – 2032 (USD Million) 74

TABLE NO. 12. : North America Addiction Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 75

TABLE NO. 13. : North America Addiction Treatment Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 75

Frequently Asked Questions:

What is the projected growth of the North America Addiction Treatment Market?

The market is projected to grow from USD 3,131.09 million in 2023 to an estimated USD 5,602.23 million by 2032, with a CAGR of 6.50% from 2024 to 2032.

What are the key drivers of market growth?

Key drivers include the increasing prevalence of substance abuse disorders, advancements in treatment methodologies, and supportive government initiatives.

How is technology influencing addiction treatment?

Technology, including telemedicine and mobile health applications, is revolutionizing addiction therapy by making treatment more accessible, efficient, and patient-centric.

What trends are impacting the addiction treatment market?

Current trends include the growing adoption of outpatient treatment programs and the integration of behavioral health and substance abuse treatment.

Who are the major players in the market?

Key players include Acadia Healthcare, Universal Health Services, Inc., and American Addiction Centers, among others, known for their innovative treatment solutions and comprehensive care services.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –